Early investigations begin to shedding perspective on how Compound 1 measures against Novo Nordisk's Drug, both innovative medications for treating adult-onset hyperglycemia . While Pegagus shown significant benefit in patient evaluations, early results suggests that Zelfitigua could deliver superior body composition outcomes, especially in patien